Is DHEA Replacement Therapy Beneficial?
Is DHEA Replacement Therapy Beneficial?
批准号:
7404214
负责人:
JOHN O. HOLLOSZY
金额:
$4.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2009-08-31
关键词:
AcheAgeAmericanArticular Range of MotionBiologicalBone DensityC-reactive proteinCartilageCellsChronicConnective TissueCoronary ArteriosclerosisDehydroepiandrosterone SulfateDevelopmentElderlyEndotheliumEstradiolExerciseFatty acid glycerol estersGene ExpressionGoalsHealthImmuneInflammationInflammatoryInsulin ResistanceInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IInterleukin-6LifeLightMaintenanceMeasuresMetabolicMetabolismMicroarray AnalysisMuscleNon-Insulin-Dependent Diabetes MellitusNumbersPainPeripheral Blood Mononuclear CellPlasmaPlayPliabilityPreventionProductionProteinsQuality of lifeRandomizedRange of motion exerciseRateReplacement TherapyResearchResearch PersonnelRoleSerumSex Hormone-Binding GlobulinStimulusTestingTestosteroneTriglyceridesTumor Necrosis Factor-alphaTumor Necrosis FactorsTyrosineVasodilationVisceralWell in selfWomanabdominal fatbonebone turnovercytokinedehydroepiandrosteronedesigndisabilitydityrosinedouble-blind placebo controlled trialfrailtyhuman TNF proteinimprovedinsightlipid metabolismmenolder womenoxidation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The major emphasis of our research on the prevention of physical frailty and loss of independence has been on the
adaptations to exercise. However, because most Americans are not motivated to exercise, we have started to evaluate
other approaches to maintenance of health and prevention of frailty. Of these, the most powerful appears to be DHEA
replacement therapy. In this context, the overall goals of this study are to determine whether long term
dehydroepiandrosterone (DHEA) replacement therapyhas beneficial effectsthat could (a) delay the development of frailty
and disability, (b) protect against development of type 2 diabetes and coronary artery disease, (c) improve quality of life,
and d) obtain information on the mechanisms of DHEAaction. DHEAand DHEA sulfate (DHEAS) plasma concentrations
peak at -20 yr of age and decline rapidly and markedly after age 25 yr. DHEAis a PPARa activator. PPARa plays major
roles in regulating lipid metabolism and controlling inflammation. DHEA also appears to have anabolic effects on muscle
and bone. The study proposed here is a randomized, double blind, placebo-controlled trial of DHEA replacement. It is
designed to determine the effects of 12 mo of DHEA replacement in 65-75 yr old women and men on (a) truncal and
visceral fat, (b) insulin resistance and serum triglycerides, (c) muscle mass and strength, (d) bone mineral density, (e)
chronic inflammation, (f) arterial-endothelium-dependent vasodilation, and (g) sense of well being. The specific aims of
this study are to test the hypotheses that 12 mo of DHEA replacement will (a) Result in significant decreases in truncal
and visceral fat by shifting metabolism to fat oxidation and increasing energy wastage; (b) Decrease insulin resistance
and decrease serum triglycerides; (c) Increase muscle mass and strength, by decreasing catabolic stimuli and increasing
anabolic stimuli; (d) Increase bone mineral density by increasing anabolic stimuli and decreasing catabolic stimuli; (e)
Reduce chronic inflammation and decrease pro-inflammatory cytokine production by peripheral blood mononuclear cells;
(f) Improve arterial endothelium dependent vasodilation; and (g) improve general sense of well being. A major emphasis
of this research is on the mechanisms responsible for the biological effectsof DHEAreplacement.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3945/ajcn.2008.27265
发表时间:
2009-05
期刊:
The American journal of clinical nutrition
影响因子:
--
作者:
[E. Weiss;K. Shah;L. Fontana;C. Lambert;J. Holloszy;D. Villareal]
通讯作者:
E. Weiss;K. Shah;L. Fontana;C. Lambert;J. Holloszy;D. Villareal
IS DHEA REPLACMENT THERAPY BENEFICIAL?
-
批准号:7603319
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2007
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
IS DHEA REPLACMENT THERAPY BENEFICIAL?
-
批准号:7377195
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2006
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
IS DHEA REPLACMENT THERAPY BENEFICIAL?
-
批准号:7198708
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2005
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
CALORIC RESTRICTION AND AGING IN HUMANS
-
批准号:7198697
-
项目类别:
-
资助金额:$23.62万
-
财政年份:2005
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
SOY PROTEIN SUPPLEMENT ALONE OR W EXERCISE IMPROVE HEALTH & CAPACITY
-
批准号:7198676
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2005
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Is DHEA Replacment Therapy Beneficial?
-
批准号:6971968
-
项目类别:
-
资助金额:$11.05万
-
财政年份:2004
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Soy Protein Supplement Alone or w Exercise Improve Health & Capacity
-
批准号:6971924
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:6971955
-
项目类别:
-
资助金额:$27.24万
-
财政年份:2004
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Is DHEA Replacement Therapy Beneficial?
-
批准号:6778242
-
项目类别:
-
资助金额:$54.55万
-
财政年份:2002
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Is DHEA Replacement Therapy Beneficial?
-
批准号:7116819
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2002
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Is DHEA Replacement Therapy Beneficial?
-
批准号:6541308
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2002
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Is DHEA Replacement Therapy Beneficial?
-
批准号:6943865
-
项目类别:
-
资助金额:$59.93万
-
财政年份:2002
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Is DHEA Replacement Therapy Beneficial?
-
批准号:6656229
-
项目类别:
-
资助金额:$51.29万
-
财政年份:2002
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:6779755
-
项目类别:
-
资助金额:$131.57万
-
财政年份:2001
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:7099534
-
项目类别:
-
资助金额:$77.88万
-
财政年份:2001
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:6658823
-
项目类别:
-
资助金额:$58.5万
-
财政年份:2001
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:6533963
-
项目类别:
-
资助金额:$133.53万
-
财政年份:2001
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:7544183
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2001
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:7269763
-
项目类别:
-
资助金额:$58.65万
-
财政年份:2001
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
Caloric Restriction and Aging in Humans
-
批准号:6644739
-
项目类别:
-
资助金额:$125.84万
-
财政年份:2001
-
负责人:JOHN O. HOLLOSZY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: